Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 191C (TMEM191C) is a predicted multi-pass membrane protein belonging to the TMEM family, characterized by its location spanning cellular membranes. The TMEM family comprises diverse proteins with roles in ion transport, regulation of cellular processes, and involvement in various diseases such as cancer and channelopathies[1][2][4]. However, as of 2025, there is no specific published evidence for the molecular function, therapeutic relevance, or disease associations of TMEM191C itself. TMEM191C is currently not considered a validated therapeutic target and its functional role remains unknown in the biomedical literature. Misspellings or fundamental errors are unlikely; rather, its designation reflects an unstudied or under-characterized protein, which is common for numerically named TMEMs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 191C (TMEM191C).